Alan Keller

3.5k citations
23 papers · 2.4k · 1 hit paper · h-index 12

Impact in

  • Hematology top 1%
    • Multiple Myeloma Research and Treatments
  • Oncology top 1%
    • Bone health and treatments
    • Cancer Treatment and Pharmacology
    • Cancer Diagnosis and Treatment
    • Peptidase Inhibition and Analysis

Papers in

    • Cancer Treatment and Pharmacology 5
    • Colorectal Cancer Treatments and Studies 2
    • Chronic Lymphocytic Leukemia Research 4
    • Estrogen and related hormone effects 2

Alan Keller

23 papers receiving 2.3k citations

Alan Keller's Hit Papers

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma 1996 · 782 citations
7820+10+20Years since publication250500750

Peers

Alan Keller
Comparison fields: 5 of 92
  • Hematology 638
  • Oncology 1.5k
  • Orthopedics and Sports Medicine 236
  • Pulmonary and Respiratory Medicine 484
  • Radiology, Nuclear Medicine and Imaging 307
Replace Michael Rader with:
Michael Rader United States
Ada Braun United States
Aristotle Bamias Greece
Pablo Maroto Spain
Thomas Moehler Germany
Donna Holloway United States
Reiner Bartl Germany
Eirini Katodritou Greece
G Spencer-Green United States
Jana Prausová Czechia
Alan Keller relative to Michael Rader United States Michael Rader's profile →
Citations per field
00.5×5.3×
Michael Rader · 1×
Citations per year

Countries citing papers authored by Alan Keller

Since Specialization
Citations

This map shows the geographic impact of Alan Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Keller more than expected).

Fields of papers citing papers by Alan Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Keller. The network helps show where Alan Keller may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan Keller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan Keller Line = papers co-authored together Alan Keller links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
Hit paper breakdown →
1996782
2 1998488
3 2010365
4 2004168
5 1994141
6 1992113
7 198498
8 199682
9 200960
10 199820
11
High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology Group.
198515
12 201812
13 198411
14 198210
15 19889
16
Prolonged survival after high-dose cytosine arabinoside and amsacrine induction in patients with previously untreated de novo acute nonlymphocytic leukemia.
19877
17 19877
18 20047
19 19947
20
Phase II studies of PCNU and bisantrene in advanced renal cell carcinoma.
19876

About Alan Keller

Alan Keller is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Hematology, having authored 23 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Hematological disorders and diagnostics (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Estrogen and related hormone effects (2 papers) and Soil and Water Nutrient Dynamics (1 paper). The work is most often cited by research in Hematology (638 citations), Oncology (1.5k citations), Orthopedics and Sports Medicine (236 citations), Pulmonary and Respiratory Medicine (484 citations) and Radiology, Nuclear Medicine and Imaging (307 citations). Alan Keller has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Joseph F. Simeone, Dirk J. Reitsma, Meletios Α. Dimopoulos, Michael J. Kovacs, Robert Knight, Oscar Ballester, Allan Lipton, John J. Seaman, Alan Lichtenstein and James R. Berenson. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Agronomy Journal, International Journal of Radiation Oncology*Biology*Physics and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact